13D Filing: Adage Capital Management and Rocket Pharmaceuticals Inc. (RCKT)

This Amendment No. 2 ("Amendment No. 2") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on October 5, 2017 (the "Original Schedule 13D...... (read more)